|18.97||-0.37 / -1.91%|
As of 3:59pm ET
|18.97||0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 43.00, with a high estimate of 48.00 and a low estimate of 24.00. The median estimate represents a +126.67% increase from the last price of 18.97.
The current consensus among 7 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.